The author discusses the link between nonalcoholic fatty liver disease (NAFLD) and obesity. The article mentions that the liver can be adversely affected by diets lacking in fruits, vegetables and dietary fibre. In NAFLD, the liver has less ability to metabolize fat. The use of the supplement...
Given the escalating epidemic of obesity and diabetes coupled with redefined diagnostic criteria, it is critical to identify the prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD). We sought to determine the prevalence and mortality outcomes of MAFLD subtypes based on diagnostic ...
• Reduce craving for fatty foods. Fish oil may help in weight regulation. • Prevent age-related prostate enlargement in males. • Prevent and treat Major Depression, Schizophrenia, Bipolar Disorder, ADHD and Anger/Aggression. Fish oil also helps treat Huntington's Disease. ...
US2009105125 2009-04-23 Methods of Treating Fatty Liver Disease US7265228 2007-09-04 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors US7196205 2007-03-27 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors US6855830 2005-02-15 Synthesis of UDP-glucose:...
EZALLOR SPRINKLE is contraindicated in patients with acute liver failure or decompensated cirrhosis. Chronic alcohol liver disease is known to increase rosuvastatin exposure. Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepat...
aNon-alcoholic fatty liver disease (NAFLD) is the most common liver disorder both in western industrialized countries and in developing countries. The most common causes of NAFLD are obesity, diabetes, and high cholesterol levels. Despite the increasing prevalence of NAFLD, the therapeutic agents are...
This study aims to investigate the relationship between two novel inflammatory markers, namely, the Systemic Inflammatory Response Index (SIRI) and the Systemic Immune Inflammatory Index (SII), as well as the all-cause and cardiovascular disease (CVD) mo
Sex differences in cardiovascular and all-cause mortality in nonalcoholic fatty liver disease in the US population. Nutr Metab Cardiovasc Dis. 2023;33(7):1349–57. Article CAS PubMed Google Scholar Walli-Attaei M, et al. Metabolic, behavioural, and psychosocial risk factors and cardiovascular ...
Cardiovascular disease CVM: Cardiovascular mortality ACM: All-cause mortality TyG index: Triglyceride glucose index CAD: Coronary artery disease PAD: Peripheral artery disease HIEC: Hyper insulinemic-euglycemic HOMA-IR: Hemostasis model assessment of insulin resistance SBP: Systolic blood press...
About onethird ofmortality isassociated withCVD. To reducethe number of deaths, risk factors thatmay predict theclinicalend-points ofCVD, including mortality, need to beidentified. Thereisevidencethat non-alcoholicfatty liver disease(NAFLD) is strongly associated withCVD. [1,2] Aclear causal...